Heidi Health AI Raises $340M, Valued at $900M

Australian health technology innovator Heidi has successfully secured a substantial $340 million in capital, comprising a $100 million Series C equity round and $240 million in growth financing. This significant funding injection propels the company's valuation to an impressive $900 million, more than doubling its worth in just one year. The Series C was spearheaded by prominent Australian venture capital firm Blackbird, with crucial participation from existing investors including Phoenix Court, Point72 Private Investments, and Headline. Complementing this equity infusion, General Catalyst's Customer Value Fund provided $240 million in revenue-based growth capital, designed to fuel sales and customer acquisition efforts without diluting existing shareholders.

Founded in Melbourne, Heidi initially gained traction as an AI-powered medical scribe, automating the transcription of patient consultations and the subsequent generation of clinical documentation. This core functionality addresses a significant pain point for healthcare professionals, who dedicate considerable time to administrative tasks. The company has since evolved its vision, now positioning itself as a comprehensive 'AI care partner' designed to support clinicians throughout their entire workday. Its expanding product suite includes 'Evidence,' a tool that provides real-time medical reference material, a versatile dictation feature compatible across various applications, and 'Remote,' its inaugural hardware offering. Integration with electronic health record (EHR) systems is a key focus, enhancing the platform's utility within existing clinical workflows.

Heidi's technological foundation is built upon proprietary, purpose-built clinical AI models, particularly for transcription and note generation, which handle the bulk of its computational demands. This strategic decision allows for greater control and customization compared to relying solely on third-party frontier models. The company emphasizes that all clinical decision-making remains firmly in the hands of the healthcare provider. This approach is critical in a sector where accuracy and trust are paramount, especially as the company targets broader applications beyond administrative support.

The company's rapid growth is underscored by its extensive reach, supporting approximately 2.8 million patient encounters weekly across 190 countries and 110 languages. To date, Heidi has facilitated over 175 million patient encounters and contributed more than 67 million clinical working hours, a threefold increase year-over-year. Annual recurring revenue has surged from $1 million to $50 million since its product launch two years ago, demonstrating strong market adoption. Notable public healthcare wins include being selected as the sole supplier for NHS England Midlands, representing the largest AI clinical documentation procurement in NHS history, and widespread adoption in Australia and New Zealand, including all emergency departments nationwide.

Looking ahead, Heidi is prioritizing expansion in German-speaking Europe (DACH region), a market that has already seen a 205% increase in monthly active users since the company's entry. Plans include doubling its headcount in the region and establishing a dedicated local leadership team to tailor its offerings to the specific needs of German, Austrian, and Swiss healthcare systems. This strategic move is supported by significant traction, including its use by Swiss Medical Network, a major private hospital group.

Navigating the complex regulatory environment is a key consideration, with a portion of the new funding allocated to regulatory compliance for advanced clinical features in Europe and the UK. The company holds numerous certifications, including ISO 27001, ISO 42001, SOC 2 Type II, and Cyber Essentials Plus, and maintains an in-house clinical research team for rigorous testing and validation. Co-founder and CEO Dr. Thomas Kelly reiterated his long-term vision: "From the day I founded Heidi, my vision always went far beyond writing doctors’ notes. I imagined an AI that accompanies clinicians through the entire working day, from documenting consultations to supporting the work that flows out of them." Heidi competes in a dynamic market alongside players like Abridge, Ambience Healthcare, and Nuance (with Microsoft's DAX Copilot), as well as regional competitors such as Nelly and Doctorly in the DACH area.